Pfizer bets on gene therapy as technology comes of age

December 8, 2014 3:06 PM

2 0

Pfizer bets on gene therapy as technology comes of age

LONDON (Reuters) - Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.

The U.S. drugmaker said on Monday it was establishing a gene therapy platform to study potential treatments, led by a top UK expert, and had struck a deal with privately owned U.S. biotech firm Spark Therapeutics to develop a treatment for haemophilia.

Read more

To category page

Loading...